(PNTG) The Pennant Group, Inc. BCG Matrix Research |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
(PNTG) The Pennant Group, Inc. Complete Analysis Pack
Visual. Strategic. Downloadable.
This The Pennant Group, Inc. BCG Matrix helps you see how the company’s business units or services may fit into the Stars, Cash Cows, Question Marks, and Dogs framework for strategy and capital allocation. This page already shows a real preview of the actual analysis, so you can review the format and content before buying. Purchase the full version to get the complete ready-to-use report.
Stars
88 agencies platform
Pennant reported 88 home health and hospice agencies at 12/31/2021, and that footprint still matters because local density drives referrals and patient retention. In post-acute care, scale in each market helps lower routing costs and lifts census faster than thin coverage. That makes this network a clear Star-style asset if growth stays ahead of share gains.
Home-based therapy
Pennant Group's home-based therapy is a Star: it bundles nursing, speech, occupational, and physical therapy in the home, which fits the shift to lower-cost care outside hospitals. Home health remains its clearest high-growth mix, and the model is built for aging patients who need repeated therapy after acute episodes. In 2025, that lower-acuity setting kept demand tied to value-based care, not just volume.
Hospice care
Pennant Group, Inc.'s hospice care is a "Star" because it delivers clinical care, education, and counseling to terminally ill patients and families, while aging demand keeps rising. The U.S. had about 58 million people age 65+ in 2022, and that base keeps expanding. With strong referral access, hospice can stay a high-growth engine.
14-state footprint
The Pennant Group, Inc. spans 14 states, from Arizona through Wyoming, which gives it a wider base for market penetration and local referrals. In a fragmented healthcare market, that footprint also supports buy-and-build expansion because smaller operators often lack scale. Multi-state coverage can lift acquisition reach, but execution still depends on keeping service quality consistent across each market.
- 14-state operating footprint
- Stronger market access and referrals
- More acquisition targets in fragmented care
- Scale helps, but execution matters
Acquisition model
Founded in 2019, The Pennant Group, Inc. has scaled fast by buying local providers and folding them into its home health, hospice, and senior living network. That M&A-led model is a star-like growth engine when capital is available, because it adds communities, boosts density, and can lift same-store scale faster than organic buildout alone.
- Founded in 2019
- Growth driven by local acquisitions
- M&A expands footprint fast
- Best when capital is cheap
Pennant’s Home Health and Hospice Power Its Fastest Growth
The Pennant Group, Inc.'s Stars are its home health and hospice units, where aging demand and home-based care keep growth strong. Its 14-state footprint and buy-and-build model help it add referrals, scale density, and expand faster than many local rivals. That makes these lines high-growth assets, but execution and quality still decide how much share they win.
| Metric | Latest cited |
|---|---|
| Operating footprint | 14 states |
| Agency count | 88 at 12/31/2021 |
| Growth engine | M&A-led expansion |
What is included in the product
Detailed Word Document
Pennant Group BCG Matrix: clear view of Stars, Cash Cows, Question Marks, and Dogs to guide invest, hold, or divest decisions.
Editable Excel File
One-page Pennant Group BCG Matrix clarifying business-unit priorities and easing strategic decision-making
Reference Sources
Provides a credible source trail for The Pennant Group, Inc., helping investors verify key assumptions quickly and make better decisions.
Cash Cows
54 communities
Pennant had 54 senior living communities at 12/31/2021, and these mature assets are the most cash-generative part of the portfolio. Once stabilized, they produce recurring resident revenue with lower ramp-up risk and steadier margins. In the BCG Matrix, this makes them a clear Cash Cow, funding growth in newer sites.
4,127 units
The Pennant Group, Inc. had 4,127 senior living units at 12/31/2021, giving it a wide installed base for steady occupancy income. A larger unit count can support recurring cash flow even when new growth slows. That makes this a clear Cash Cow asset in the BCG Matrix.
Resident services
Resident services is a cash cow because meals, housekeeping, activities, and daily-living help create recurring monthly billing. Once Pennant Group communities are full, cash flow is steadier, and demand should stay supported as the U.S. 65+ population reaches about 59 million in 2025, keeping senior living occupancy and services relevant.
Established markets
The Pennant Group, Inc. already operates across 13 states, mostly in the West and Central U.S., so its mature local brands can lean on stable referral streams and repeat demand in home health and hospice. With low incremental growth needs in these markets, these businesses fit the BCG "cash cow" profile: steady share, modest capex, and reliable cash generation.
- 13-state footprint supports referrals
- Repeat demand lowers sales risk
- Mature markets need less reinvestment
- Cash flow can fund growth bets
Shared overhead
Shared overhead is a cash cow for The Pennant Group, Inc. because corporate support costs can be spread across more agencies and communities, so each site carries less admin burden as the network grows. The payoff is strongest in mature locations, where sales spend is already lower and more of each dollar can flow to operating profit. In plain terms: bigger base, lower per-site cost.
- Shared services cut unit costs
- Mature sites need less sales spend
- Scale improves margin leverage
Pennant Group’s Senior Living Base Is a Reliable Cash Cow
Pennant Group's mature senior living base, 54 communities and 4,127 units at 12/31/2021, fits a Cash Cow profile because it can keep generating recurring resident revenue with less ramp-up risk. The 13-state footprint also supports repeat referrals and steadier cash flow, while shared overhead lifts margins. These assets can fund growth in newer sites.
| Cash cow driver | Data |
|---|---|
| Senior living communities | 54 |
| Senior living units | 4,127 |
| Geographic reach | 13 states |
| Cash use | Funds growth bets |
Preview the Actual Deliverable
The Pennant Group, Inc. Reference Sources
You’re previewing the exact The Pennant Group, Inc. BCG Matrix document you’ll receive after purchase. No demo content, no placeholders—just the same fully formatted report. Once purchased, the file is delivered ready for immediate use in analysis, planning, or presentation.
Dogs
Low-census sites
Low-census sites are the clearest Dog cases for The Pennant Group, Inc.: in 2025, revenue was about $1.3 billion, but a weak census can still leave labor and rent fixed. If a site cannot lift volume fast, it may burn cash instead of adding it. Small agencies with no visible turnaround should be cut or merged fast.
Slow-growth locations
Slow-growth locations are weak Dogs for The Pennant Group, Inc. because limited population gains cap new admissions and patient volume. In a 2025-style low-growth market, a site with weak share can sit near break-even for years, tying up capital with little upside. These assets are usually better pruning targets than expansion bets, since return on invested capital stays thin.
Turnaround-heavy assets
Some Pennant Group, Inc. sites need constant staffing fixes, occupancy repair, and extra oversight, so they eat capital without a clear payback. That is why turnaround-heavy assets fit BCG dog logic: low growth, weak share, and high drag on management time. In 2025/2026, the right move is often to cap spend, fix only the few with clear upside, and exit the rest.
High fixed-cost bases
Pennant Group’s senior living and home care arms are high fixed-cost dogs: labor, rent, and site overhead do not fall fast when census softens. In 2025, even a small volume dip can squeeze margins, because wage costs stay sticky while revenue resets lower. Weak-occupancy assets can turn into cash traps fast.
- Labor is the biggest cost line.
- Lower census hits margins first.
- Weak sites can drain cash.
Non-core laggards
Non-core laggards at The Pennant Group, Inc. are older sites that sit outside the company’s best operating model. They usually lack scale, brand pull, or referral flow, so they can drag margins and cash conversion; if turnaround paths are weak, divestiture is the cleaner move.
- Older sites often underwrite lower growth.
- Weak referrals hurt census and revenue.
- Scale gaps raise labor and overhead costs.
- Exit fast if improvement is unlikely.
Pennant Group’s Dogs: Low Occupancy, High Drag
Dogs for The Pennant Group, Inc. are low-census, slow-growth sites that still carry fixed labor and rent. In 2025, revenue was about $1.3 billion, but weak occupancy can still trap cash and drag margins. If share and referrals do not improve fast, these sites should be cut, merged, or sold.
| Dog factor | 2025/2026 signal |
|---|---|
| Revenue | About $1.3 billion |
| Growth | Low in weak markets |
| Cost drag | Labor and rent stay fixed |
| Action | Prune or divest |
Question Marks
De novo agencies
De novo agencies start with near-zero share, so they fit the Question Mark box in Pennant Group, Inc.'s BCG Matrix. They can be attractive only if referral growth ramps fast; otherwise, they absorb startup cash and leadership time before scale kicks in. In home health and hospice, weak census growth can leave new sites underused for many months.
New senior living builds
New senior living builds are classic question marks for The Pennant Group, Inc. because lease-up starts slow, so early occupancy can stay well below break-even and losses often hit before cash flow turns positive. The upside is real: U.S. seniors 65+ keep rising, which supports long-term demand, but each new community still faces local competition and timing risk. Until a build reaches stable occupancy and margins, it stays a question mark, not a star.
Higher-acuity care
Higher-acuity care can lift The Pennant Group, Inc. revenue per patient by shifting more visits, therapy, and skilled nursing into the mix, but it also needs more RN staffing, training, and clinical systems. That makes the upside real but uneven, so this stays a question mark: strong growth potential, yet execution risk can hit margins fast if care quality slips.
New-state expansion
New-state expansion can give The Pennant Group, Inc. a fresh growth lane, but every launch brings new licensure, staffing, and payer rules that can slow margins. In the latest reported year, revenue grew while the company kept adding locations, so the upside is real, but local execution has to be fast. Success starts with quick referral wins and tight compliance.
- New states expand addressable demand.
- Each state adds regulatory friction.
- Early share stays low, so speed matters.
Value-based partnerships
Value-based partnerships are a Question Mark for The Pennant Group, Inc. They can lift margins if utilization stays tight, but the model is still uneven across post-acute markets.
- 2025 Medicare Advantage enrollment reached about 54%.
- Risk-based contracts are growing, but not uniform.
- Upside is high if care use stays controlled.
- Share gains are still uncertain, so capital remains at risk.
So, the path can improve economics, but adoption depth and contract mix still make this a bet, not a sure win.
Pennant’s Growth Bets: High Upside, Early Cash Burn
Question Marks in The Pennant Group, Inc. are still de novo agencies, new senior living builds, and newer value-based contracts: each starts with low share, heavy startup cash use, and slow early margins. In 2025, Medicare Advantage enrollment was about 54%, but that only helps if Pennant Group, Inc. can win referrals and keep costs tight.
| Item | 2025 signal |
|---|---|
| Medicare Advantage enrollment | About 54% |
| Early share | Near zero |
| Risk | Startup cash burn |
| Upside | Margin lift if scaled |
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.